Evidence map›Paper›PMID 27601583›Full record

ArticleMolecular and cellular biology2016

Cytoplasmic ATXN7L3B Interferes with Nuclear Functions of the SAGA Deubiquitinase Module.

Wenqian Li, Boyko S Atanassov, Xianjiang Lan, Ryan D Mohan, Selene K Swanson, Aimee T Farria, Laurence Florens, Michael P Washburn, Jerry L Workman, Sharon Y R Dent

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Sharing the SAGA.Trends in biochemical sciences · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Wenqian LiDepartment of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Smithville, Texas, USA.
Boyko S AtanassovDepartment of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Smithville, Texas, USA.
Xianjiang LanDepartment of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Smithville, Texas, USA.
Ryan D MohanSchool of Biological Sciences, Division of Cell Biology and Biophysics, University of Missouri-Kansas City, Kansas City, Missouri, USA.
Selene K SwansonStowers Institute for Medical Research, Kansas City, Missouri, USA.
Aimee T FarriaDepartment of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Smithville, Texas, USA.
Laurence FlorensStowers Institute for Medical Research, Kansas City, Missouri, USA.
Michael P WashburnStowers Institute for Medical Research, Kansas City, Missouri, USA.
Jerry L WorkmanStowers Institute for Medical Research, Kansas City, Missouri, USA.
Sharon Y R DentDepartment of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Smithville, Texas, USA sroth@mdanderson.org.
The University of Texas MD Anderson Cancer Center · USStowers Institute for Medical Research · USUniversity of Missouri–Kansas City · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Transcription regulation in chromatinR35GM118068 · NIGMS · STOWERS INSTITUTE FOR MEDICAL RESEARCH · PI JERRY L WORKMAN · 2016 to 2026
$4.2M
Defining USP22 Functions During Mammalian DevelopmentR01GM096472 · NIGMS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DENT, SHARON Y. R. · 2012 to 2015
$1.3M
Analysis of metazoan SAGA complex function in gene expressionR01GM099945 · NIGMS · STOWERS INSTITUTE FOR MEDICAL RESEARCH · PI ABMAYR, SUSAN M, WORKMAN, JERRY L · 2012 to 2015
$1.2M
NCI NIH HHS P30 CA016672NIGMS NIH HHS R01 GM096472NIGMS NIH HHS R01 GM099945NIGMS NIH HHS R35 GM118068
6 · The paper itself

Abstract

The SAGA complex contains two enzymatic modules, which house histone acetyltransferase (HAT) and deubiquitinase (DUB) activities. USP22 is the catalytic subunit of the DUB module, but two adaptor proteins, ATXN7L3 and ENY2, are necessary for DUB activity toward histone H2Bub1 and other substrates. ATXN7L3B shares 74% identity with the N-terminal region of ATXN7L3, but the functions of ATXN7L3B are not known. Here we report that ATXN7L3B interacts with ENY2 but not other SAGA components. Even though ATXN7L3B localizes in the cytoplasm, ATXN7L3B overexpression increases H2Bub1 levels, while overexpression of ATXN7L3 decreases H2Bub1 levels. In vitro, ATXN7L3B competes with ATXN7L3 to bind ENY2, and in vivo, knockdown of ATXN7L3B leads to concomitant loss of ENY2. Unlike the ATXN7L3 DUB complex, a USP22-ATXN7L3B-ENY2 complex cannot deubiquitinate H2Bub1 efficiently in vitro Moreover, ATXN7L3B knockdown inhibits migration of breast cancer cells in vitro and limits expression of ER target genes. Collectively, our studies suggest that ATXN7L3B regulates H2Bub1 levels and SAGA DUB activity through competition for ENY2 binding.

Indexed as

Breast NeoplasmsCell MovementCell NucleusCytoplasmFemaleGene Knockdown TechniquesHEK293 CellsHistonesHumansMCF-7 CellsThiolester HydrolasesTranscription FactorsUbiquitin ThiolesteraseUp-RegulationATXN7L3B protein, humanATXN7L3 protein, humanEny2 protein, humanHistonesThiolester HydrolasesTranscription FactorsUbiquitin ThiolesteraseUsp22 protein, human

Identifiers

PMID27601583
PMCPMC5086525
OpenAlexW2515935824

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.